| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2022 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345N | GREENWOOD VILLAGE | CO | 80111-1941 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 000 | 4 | NIH | 5/3/2024 | $0 |
| | 2024 | 2021 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345N | GREENWOOD VILLAGE | CO | 80111-1941 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 4 | NIH | 1/29/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $601,625 ) |
| | 2022 | 2022 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345 N | GREENWOOD VILLAGE | CO | 80111-1909 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 000 | 4 | NIH | 12/20/2021 | $600,000 |
| | 2022 | 2022 | BIOMIMETIX JV LLC | 5340 S QUEBEC ST | GREENWOOD VILLAGE | CO | 80111-1941 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 4 | NIH | 5/17/2022 | $1,625 |
| | 2022 | 2020 | BIOMIMETIX JV LLC | 5340 S QUEBEC ST | GREENWOOD VILLAGE | CO | 80111-1941 | ARAPAHOE | USA | R41NS110252 | Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | 000 | 2 | NIH | 3/8/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $2,400,000 ) |
| | 2021 | 2021 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345 N | GREENWOOD VILLAGE | CO | 80111-1909 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 000 | 3 | NIH | 2/12/2021 | $400,000 |
| | 2021 | 2021 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345 N | GREENWOOD VILLAGE | CO | 80111-1909 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 4 | NIH | 8/9/2021 | $2,000,000 |
|
| Issue Date FY: 2020 ( Subtotal = $3,227,823 ) |
| | 2020 | 2020 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 3 | NIH | 5/22/2020 | $2,000,000 |
| | 2020 | 2020 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 001 | 2 | NIH | 1/9/2020 | $1,000,000 |
| | 2020 | 2020 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R41NS110252 | Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | 000 | 2 | NIH | 9/11/2020 | $227,823 |
| | 2020 | 2018 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345 N | GREENWOOD VILLAGE | CO | 80111-1909 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 002 | 1 | NIH | 9/28/2020 | $0 |
| | 2020 | 2018 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 000 | 1 | NIH | 1/9/2020 | $0 |
| | 2020 | 2016 | BIOMIMETIX JV, LLC | 5340 S QUEBEC ST STE 345 N | GREENWOOD VILLAGE | CO | 80111-1909 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 001 | 2 | NIH | 9/28/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $247,352 ) |
| | 2019 | 2019 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R41NS110252 | Pharmacologic Suppression of Reperfusion Injury Following Endovascular Thrombectomy In Stroke. | 000 | 1 | NIH | 9/3/2019 | $247,352 |
| | 2019 | 2016 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 2 | NIH | 6/17/2019 | $0 |
|
| Issue Date FY: 2018 ( Subtotal = $300,000 ) |
| | 2018 | 2018 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA228694 | BMX-001 as a Therapeutic Agent for Treatment of Multiple Brain Metastases. | 000 | 1 | NIH | 7/6/2018 | $300,000 |
| | 2018 | 2016 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113-6100 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 2 | NIH | 8/17/2018 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $1,023,555 ) |
| | 2016 | 2016 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 2 | NIH | 7/28/2016 | $1,023,555 |
|
| Issue Date FY: 2015 ( Subtotal = $976,447 ) |
| | 2015 | 2015 | BIOMIMETIX JV, LLC | 4650 S FOREST ST | ENGLEWOOD | CO | 80113 | ARAPAHOE | USA | R44CA195749 | BMX-001 as a Therapeutic Agent for Treatment of High-Grade Gliomas | 000 | 1 | NIH | 9/16/2015 | $976,447 |
|
|
